127294-70-6 | 1-cyclopropyl-6-fluoro-8-methoxy-7-[3-(methylamino)piperidin-1-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

Packsize	Purity	Availability	Price	Discounted Price
500mg	98%	in stock	$48.00	$34.00
1g	98%	in stock	$63.00	$45.00
10g	98%	in stock	$185.00	$130.00
100g	98%	in stock	$1,506.00	$1,054.00

Description

• Catalog Number: AA42439
• Chemical Name: 1-cyclopropyl-6-fluoro-8-methoxy-7-[3-(methylamino)piperidin-1-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
• CAS Number: 127294-70-6
• Molecular Formula: C20H24FN3O4
• Molecular Weight: 389.4207
• MDL Number: MFCD00864925
• SMILES: CNC1CCCN(C1)c1c(F)cc2c(c1OC)n(cc(c2=O)C(=O)O)C1CC1

Computed Properties

• Complexity: 668
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 28
• Hydrogen Bond Acceptor Count: 8
• Hydrogen Bond Donor Count: 2
• Rotatable Bond Count: 5
• Undefined Atom Stereocenter Count: 1
• XLogP3: 0.6

Literature

• Alterations of protein complexes and pathways in genetic information flow and response to stimulus contribute to Escherichia coli resistance to balofloxacin.

  Molecular bioSystems 20120901

• Downregulation of Na(+)-NQR complex is essential for Vibrio alginolyticus in resistance to balofloxacin.

  Journal of proteomics 20120517

• In the quest of drugs for bad bugs: are newer fluoroquinolones any better?

  Journal of laboratory physicians 20110101

• Synthesis and in vitro antimycobacterial activity of balofloxacin ethylene isatin derivatives.

  European journal of medicinal chemistry 20100801

• Aquatic photochemistry of fluoroquinolone antibiotics: kinetics, pathways, and multivariate effects of main water constituents.

  Environmental science & technology 20100401

• Gatifloxacin, moxifloxacin, and balofloxacin resistance due to mutations in the gyrA and parC genes of Staphylococcus epidermidis strains isolated from patients with endophthalmitis, corneal ulcers and conjunctivitis.

  Ophthalmic research 20090101

• Ethyl 1-cyclo-propyl-6,7-difluoro-8-meth-oxy-4-oxo-1,4-dihydro-quinoline-3-carboxyl-ate.

  Acta crystallographica. Section E, Structure reports online 20081101

• [Synthesis and antibacterial activity of 7-(3-amino-4-alkoxyimino-1 -piperidyl) -quinolones].

  Yao xue xue bao = Acta pharmaceutica Sinica 20080801

• [Determination of balofloxacin in human plasma by HPLC with solid-phase extraction].

  Se pu = Chinese journal of chromatography 20071101

• High performance liquid chromatography-electrospray ionization mass spectrometric determination of balofloxacin in human plasma and its pharmacokinetics.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070501

• [Studies on the reaction of balofloxacin with bovine serum albumin].

  Guang pu xue yu guang pu fen xi = Guang pu 20060801

• Electrophysiological safety of novel fluoroquinolone antibiotic agents gemifloxacin and balofloxacin.

  Drug and chemical toxicology 20060101

• [Interaction between balofloxacin and DNA and the influence of Mg2+ on the interaction].

  Yao xue xue bao = Acta pharmaceutica Sinica 20050701

• Balofloxacin Choongwae.

  Current opinion in investigational drugs (London, England : 2000) 20030201

• [In vitro antimycobacterial activities of a new quinolone, balofloxacin].

  Kekkaku : [Tuberculosis] 20010101

• History of quinolones and their side effects.

  Chemotherapy 20010101

• [In vitro anti-MAC activities of new quinolones in focus (2)].

  Kekkaku : [Tuberculosis] 19960901

• [Determination of antimycobacterial activities of fluoroquinolones against clinical isolates of Mycobacterium tuberculosis: comparative determination with egg-based Ogawa and agar-based Middlebrook 7H10 media].

  Kekkaku : [Tuberculosis] 19960801